Price Crosses Moving Average
Previous Close | 1.3300 |
Open | 1.3300 |
Bid | 1.2900 x 3200 |
Ask | 1.3200 x 1800 |
Day's Range | 1.2650 - 1.3500 |
52 Week Range | 0.7620 - 9.7500 |
Volume | |
Avg. Volume | 4,628,423 |
Market Cap | 712.974M |
Beta (5Y Monthly) | -0.02 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.0200 |
Earnings Date | May 09, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 2.84 |
Cano Health, Inc. ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today sent a letter to stockholders in connection with its June 15, 2023 Annual Meeting. The Company's Board of Directors unanimously recommended that stockholders vote the WHITE Proxy Card "FOR" the re-election of its highly qualified, independent directors and the proposed reverse stock split.
NEW YORK & MIAMI, June 07, 2023--Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the "Group" or "we"), who recently resigned as members of the Board of Directors (the "Board") of Cano Health, Inc. ("Cano" or the "Company") (NYSE: CANO) and collectively own an approximately 35% equity stake in the Company, today announced that both leading independent proxy advisory firms – Institutional Shareholder Services, Inc. ("ISS") and Glass, Lewis & Co.
Cano Health, Inc. ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today issued the following statement commenting on the reports issued by Institutional Shareholder Services ("ISS") and Glass Lewis regarding the Company's June 15, 2023 Annual Stockholders' Meeting:
NEW YORK & MIAMI, June 02, 2023--Elliot Cooperstone, Lewis Gold and Barry Sternlicht today released the following letter to Cano Health, Inc. (NYSE: CANO) stockholders:
Cano Health, Inc. ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today announced that it has published an investor presentation to its investor relations website in connection with its upcoming Annual Stockholders' Meeting (the "Annual Meeting"), scheduled for June 15, 2023. The presentation is also being filed with the U.S. Securities and Exchange Commission.
Cano Health, Inc. ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today announced the appointment of Frederick S. Green as its Interim Chief Legal Officer, effective immediately.
NEW YORK & MIAMI, May 30, 2023--Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the "Group," "us" or "we"), who recently resigned as members of the Board of Directors (the "Board") of Cano Health, Inc. ("Cano" or the "Company") (NYSE: CANO), today announced that they have issued a presentation that outlines the urgent case for changes in leadership and strategy at the Company. The Group, which holds an approximately 35% equity stake in Cano, is
NEW YORK & MIAMI, May 25, 2023--Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the "Group," "us" or "we"), who recently resigned as members of the Board of Directors (the "Board") of Cano Health, Inc. ("Cano" or the "Company") (NYSE: CANO), today announced that they have filed a definitive proxy statement with the U.S. Securities and Exchange Commission in order to solicit WITHHOLD votes against the re-election of Dr. Alan Muney, Chair of Cano
Cano Health, Inc. ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today announced that it has filed its definitive proxy statement with the Securities and Exchange Commission and sent a letter to shareholders in connection with its upcoming Annual Stockholders' Meeting (the "Annual Meeting"), which is scheduled for June 15, 2023.
NEW YORK & MIAMI, May 18, 2023--Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the "Group," "us" or "we"), who recently resigned as members of the Board of Directors (the "Board") of Cano Health, Inc. ("Cano" or the "Company") (NYSE: CANO), today announced that they have submitted a notice to the Company to nominate two highly qualified, independent candidates – Joseph Berardo, Jr. and Guy P. Sansone – for election to the Board of Directors (t
Cano Health, Inc. ( NYSE:CANO ) defied analyst predictions to release its quarterly results, which were ahead of market...
NEW YORK & MIAMI, May 11, 2023--Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the "Group", "us" or "we"), who recently resigned as members of the Board of Directors (the "Board") of Cano Health, Inc. ("Cano" or the "Company") (NYSE: CANO), today issued the below letter to shareholders regarding its intended efforts at the 2023 Annual Meeting of Shareholders (the "Annual Meeting").
Cano Health, Inc. (CANO) delivered earnings and revenue surprises of 14.29% and 3.67%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), a leading value-based primary care provider and population health company, today announced financial results for the first quarter ended March 31, 2023.
The Beauty Health Company (SKIN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cano Health, Inc. (CANO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NEW YORK & MIAMI, April 26, 2023--Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the "Group" or "we"), who recently resigned as members of the Board of Directors (the "Board") of Cano Health, Inc. ("Cano" or the "Company") (NYSE: CANO), today issued the below letter to shareholders.
Humana, Viatris, agilon health and Cano Health are included in this Analyst Blog.
Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), a leading value-based primary care provider and population health company, will release its financial results for the first quarter 2023 after the market closes on Tuesday, May 9, 2023, and will host a conference call at 5:00 PM Eastern Time the same day to review its business and financial results.
Growing patient volumes, admissions, health awareness and technological improvement in the first quarter are likely to have aided healthcare players like Humana (HUM), Viatris (VTRS), agilon health (AGL) and Cano Health (CANO).
Facilities to Deliver Health & Wellness Offerings for the Senior Community Cano Health_18469 South Dixie Highway in Cutler Bay_staff Cano Health_18469 South Dixie Highway in Cutler Bay_staff Cano Health_18469 South Dixie Highway in Cutler Bay_exterior Cano Health_18469 South Dixie Highway in Cutler Bay_exterior Miami, FL, April 24, 2023 (GLOBE NEWSWIRE) -- Cano Health, Inc. (“Cano Health” or the “Company”), a leading value-based primary care provider and population health company, announced it h
Cano Health announced the separation of its chairman and CEO position, as it named Solomon Trujillo non-executive chairman of its board. The Miami-based health care provider (NYSE: CANO) has been under pressure to shake up its leadership by former board member Barry Sternlicht, the billionaire chairman and CEO of Miami Beach-based Starwood Capital Group. Also on Monday, Sternlicht issued a statement calling for competitive board member elections at Cano Health.
Cano Health, Inc. ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today announced that it has separated the roles of Chairman and Chief Executive Officer and appointed Solomon Trujillo, the Company's lead independent director, as the non-executive chairman of the Company's Board of Directors, effective immediately. The change will enable Dr. Marlow Hernandez to focus his attention on his role as Chief Executive Officer, in addition to
Cano Health, Inc. ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today issued the following letter from its Board of Directors to shareholders.
NEW YORK & MIAMI, April 17, 2023--Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the "Group" or "we"), who recently resigned as members of the Board of Directors (the "Board") of Cano Health, Inc. ("Cano" or the "Company") (NYSE: CANO), today issued the following statement: